REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 136 filers reported holding REVANCE THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 0.72 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,366,436 | +258.4% | 53,988 | +356.1% | 0.20% | +288.5% |
Q1 2023 | $381,302 | -43.0% | 11,838 | -67.3% | 0.05% | -45.3% |
Q4 2022 | $669,175 | +187.2% | 36,250 | +360.8% | 0.10% | +131.7% |
Q2 2021 | $233,000 | -64.6% | 7,866 | -70.0% | 0.04% | -51.2% |
Q3 2020 | $659,000 | +137.9% | 26,199 | +130.6% | 0.08% | +133.3% |
Q2 2020 | $277,000 | +136.8% | 11,360 | +43.5% | 0.04% | +125.0% |
Q1 2020 | $117,000 | -22.0% | 7,918 | -14.1% | 0.02% | -36.0% |
Q4 2019 | $150,000 | – | 9,213 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 3,342,047 | $94,714,000 | 24.58% |
Palo Alto Investors LP | 2,673,313 | $75,762,000 | 3.97% |
Evolutionary Tree Capital Management, LLC | 89,348 | $2,532,000 | 1.93% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,121,152 | $31,773,000 | 1.12% |
ArrowMark Colorado Holdings LLC | 2,964,135 | $84,004,000 | 0.65% |
Rhenman & Partners Asset Management AB | 220,000 | $6,235,000 | 0.51% |
Fosun International Ltd | 233,841 | $6,627,000 | 0.43% |
OSTERWEIS CAPITAL MANAGEMENT INC | 174,970 | $4,959,000 | 0.30% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 76,671 | $2,173,000 | 0.27% |
Tekla Capital Management LLC | 213,808 | $6,059,000 | 0.21% |